Cargando…
Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919186/ https://www.ncbi.nlm.nih.gov/pubmed/33658921 http://dx.doi.org/10.3389/fphar.2020.565535 |
| _version_ | 1783658085360861184 |
|---|---|
| author | Cao, Zhang-qi Wang, Xue-xi Lu, Li Xu, Jing-wen Li, Xiao-bin Zhang, Guang-ru Ma, Zhan-jun Shi, An-chen Wang, Yan Song, Yu-jun |
| author_facet | Cao, Zhang-qi Wang, Xue-xi Lu, Li Xu, Jing-wen Li, Xiao-bin Zhang, Guang-ru Ma, Zhan-jun Shi, An-chen Wang, Yan Song, Yu-jun |
| author_sort | Cao, Zhang-qi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7919186 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79191862021-03-02 Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling Cao, Zhang-qi Wang, Xue-xi Lu, Li Xu, Jing-wen Li, Xiao-bin Zhang, Guang-ru Ma, Zhan-jun Shi, An-chen Wang, Yan Song, Yu-jun Front Pharmacol Pharmacology Frontiers Media S.A. 2020-11-20 /pmc/articles/PMC7919186/ /pubmed/33658921 http://dx.doi.org/10.3389/fphar.2020.565535 Text en Copyright © 2020 Cao, Wang, Lu, Xu, Li, Zhang, Ma, Shi, Wang and Song. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Cao, Zhang-qi Wang, Xue-xi Lu, Li Xu, Jing-wen Li, Xiao-bin Zhang, Guang-ru Ma, Zhan-jun Shi, An-chen Wang, Yan Song, Yu-jun Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling |
| title | Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling |
| title_full | Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling |
| title_fullStr | Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling |
| title_full_unstemmed | Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling |
| title_short | Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling |
| title_sort | corrigendum: β-sitosterol and gemcitabine exhibit synergistic anti-pancreatic cancer activity by modulating apoptosis and inhibiting epithelial–mesenchymal transition by deactivating akt/gsk-3β signaling |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919186/ https://www.ncbi.nlm.nih.gov/pubmed/33658921 http://dx.doi.org/10.3389/fphar.2020.565535 |
| work_keys_str_mv | AT caozhangqi corrigendumbsitosterolandgemcitabineexhibitsynergisticantipancreaticcanceractivitybymodulatingapoptosisandinhibitingepithelialmesenchymaltransitionbydeactivatingaktgsk3bsignaling AT wangxuexi corrigendumbsitosterolandgemcitabineexhibitsynergisticantipancreaticcanceractivitybymodulatingapoptosisandinhibitingepithelialmesenchymaltransitionbydeactivatingaktgsk3bsignaling AT luli corrigendumbsitosterolandgemcitabineexhibitsynergisticantipancreaticcanceractivitybymodulatingapoptosisandinhibitingepithelialmesenchymaltransitionbydeactivatingaktgsk3bsignaling AT xujingwen corrigendumbsitosterolandgemcitabineexhibitsynergisticantipancreaticcanceractivitybymodulatingapoptosisandinhibitingepithelialmesenchymaltransitionbydeactivatingaktgsk3bsignaling AT lixiaobin corrigendumbsitosterolandgemcitabineexhibitsynergisticantipancreaticcanceractivitybymodulatingapoptosisandinhibitingepithelialmesenchymaltransitionbydeactivatingaktgsk3bsignaling AT zhangguangru corrigendumbsitosterolandgemcitabineexhibitsynergisticantipancreaticcanceractivitybymodulatingapoptosisandinhibitingepithelialmesenchymaltransitionbydeactivatingaktgsk3bsignaling AT mazhanjun corrigendumbsitosterolandgemcitabineexhibitsynergisticantipancreaticcanceractivitybymodulatingapoptosisandinhibitingepithelialmesenchymaltransitionbydeactivatingaktgsk3bsignaling AT shianchen corrigendumbsitosterolandgemcitabineexhibitsynergisticantipancreaticcanceractivitybymodulatingapoptosisandinhibitingepithelialmesenchymaltransitionbydeactivatingaktgsk3bsignaling AT wangyan corrigendumbsitosterolandgemcitabineexhibitsynergisticantipancreaticcanceractivitybymodulatingapoptosisandinhibitingepithelialmesenchymaltransitionbydeactivatingaktgsk3bsignaling AT songyujun corrigendumbsitosterolandgemcitabineexhibitsynergisticantipancreaticcanceractivitybymodulatingapoptosisandinhibitingepithelialmesenchymaltransitionbydeactivatingaktgsk3bsignaling |